As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
Announcement
Featured Articles
PAMs inhibits monoamine oxidase a activity and reduces glioma tumor growth, a potential adjuvant treatment for glioma
Natural plant antimicrobial solution alone or co-administration with low doses of temozolomide may be a potential adjuvant to reduce the toxicity of temozolomide and to evade drug resistance for the effective treatment of glioma.
© skymoon13 / stock.adobe.com
Determining the antimicrobial activity of plant extracts and publishing the results
In this review one of our Section Editors, Jacobus Eloff, provides advice for researchers who wish to investigate the antimicrobial properties of plant derived extracts.
BMC Series Focus Issues
October: Focus on Stem Cells
With Stem Cell Awareness day on the 13th October this year we have compiled an article collection from across different BMC Series journals covering aspects of basic stem cell biology; in vitro differentiation studies; stem-cell based therapy studies for various conditions in animal models; technical advancements and ethical issues.
September: Patient and public involvement in research
In recognition of World Patient Safety Awareness day on 17th September, the BMC Series presents a focus issue on Patient and Public Involvement (PPI) in research. We have collated free-to-read content from across our journals - showcasing patient perspectives, research into the study of PPI, and engaging public partners as co-authors in research.
BMC Complementary Medicine and Therapies – we’ve updated our Research Standards
Pixabay
We are pleased to announce the new Research Standards for manuscripts submitted to BMC Complementary Medicine and Therapies. These changes renew the journal’s commitment to providing objective evidence for the efficacy or utilisation of complementary and alternative therapies. We will consider all manuscripts which meet these criteria. Click the button below to read more.
Read MoreArticles
-
-
Revealing the potential mechanism of Astragalus membranaceus improving prognosis of hepatocellular carcinoma by combining transcriptomics and network pharmacology
-
Utilization of complementary and traditional medicine practitioners among middle-aged and older adults in India: results of a national survey in 2017–2018
-
The benefit of combining curcumin, bromelain and harpagophytum to reduce inflammation in osteoarthritic synovial cells
-
An in vitro study of an Artocarpus heterophyllus substance as a hepatitis C antiviral and its combination with current anti-HCV drugs
-
In vitro antibacterial activity of some plant essential oils
-
Frankincense oil derived from Boswellia carteri induces tumor cell specific cytotoxicity
-
Inhibitory effect of green coffee bean extract on fat accumulation and body weight gain in mice
-
Antioxidant activity, total phenolic and total flavonoid contents of whole plant extracts Torilis leptophylla L
-
Clinical research evidence of cupping therapy in China: a systematic literature review
Aims and scope
BMC Complementary Medicine and Therapies is an open access journal publishing original peer-reviewed research articles on interventions and resources that complement or replace conventional therapies, with a specific emphasis on research that explores the biological mechanisms of action, as well as their efficacy, safety, costs, patterns of use and/or implementation.
Peer Review Taxonomy
This journal is participating in a pilot of NISO/STM's Working Group on Peer Review Taxonomy, to identify and standardize definitions and terminology in peer review practices in order to make the peer review process for articles and journals more transparent. Further information on the pilot is available here.
The following summary describes the peer review process for this journal:
- Identity transparency: Single anonymized
- Reviewer interacts with: Editor
- Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication
We welcome your feedback on this Peer Review Taxonomy Pilot. Please can you take the time to complete this short survey.
About to Submit a Systematic Review?
BMC Complementary Medicine and Therapies is affiliated with Cochrane Complementary Medicine. The purpose of this affiliation is to improve the standard of Systematic Review reporting at the journal. Click the link below for an Editorial with more information on this partnership and how the journal treats Systematic Reviews.
Read MoreEditor
Anne Menard, BioMed Central
Assistant Editors
Esther Fagelson, BioMed Central
Kate Gaines, BioMed Central
Senior Editorial Board Members
Victor Kuete, University of Dschang
Jianping Liu, Beijing University of Chinese Medicine
Insop Shim, Kyung Hee University
Jenny Wilkinson, Charles Sturt University
Amie Steel, University of Technology Sydney
Insop Shim, Section Editor
I am currently a professor at College of Medicine, Kyung Hee University. I hold a Ph.D. in Biopsychology (Behavioral Neuroscience) from University of Illinois at Chicago and completed my post-doctoral fellowship at the Department of Psychiatry, School of Medicine University of Illinois. I am a member of the Society for Neuroscience and have served as an organizing committee of many International conferences and served as the Editor-in-Chief of Korean Society of Stress Medicine and Executive Editor of Experimental Neurobiology.
My research expertise is in the areas of neural mechanisms responsible for motivational behaviors including stress, drugs of abuse, and learning and memory. It is the goal of my research in particular, to elucidate both the effects and the mechanisms of action of the herbal medicine or complementary and alternative medicine (CAM) using animal models of stress-related diseases such as anxiety, depression, insomnia or learning and memory. I have joined a board member since Aug, 2016.
BMC Series Blog
-
Can Kidney Disease Affect Your Thinking?
14 October 2021
-
Highlights of the BMC Series – September 2021
11 October 2021
-
Affiliated with
-
BMC Complementary Medicine and Therapies is affiliated with ISCMR, the international society for complementary medicine research and Cochrane Complementary Medicine
Follow
Annual Journal Metrics
-
Speed
83 days to first decision for reviewed manuscripts only
39 days to first decision for all manuscripts
217 days from submission to acceptance
23 days from acceptance to publicationCitation Impact
For BMC Complementary and Alternative Medicine (former title)
3.659 - 2-year Impact Factor
3.767 - 5-year Impact Factor
1.505 - Source Normalized Impact per Paper (SNIP)
0.764 - SCImago Journal Rank (SJR)Usage
2,163,259 downloads